Skip to content
OpenCapital
Get started

Veritone, Inc. VERI Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$20.3M-9.8%
Gross profit$13.7M-6.3%
Operating income-$19.4M+10.2%
Net income-$19.5M+1.8%
EPS (diluted)-$0.21+48.8%

Balance sheet

See full
Cash & equivalents$15.1M-6.2%
Total debt$47.1M+4,470%
Total equity$49.0M+232%
Total assets$155.2M-22.3%

Cash flow

See full
Operating cash flow-$11.5M+32.6%
CapEx$534.0K-60.5%
Free cash flow-$12.0M+34.6%

Valuation

See full
Market cap$121.77M+77.1%
Enterprise value$153.8M+175%
P/S1.4×+0.6×

Profitability

See full
Gross margin68.5%-0.3pp
Operating margin-87.5%-5.6pp
Net margin-123.4%—
FCF margin-57.6%-9.0pp

Returns & leverage

See full
Return on equity-348.4%—
Debt / equity1×+0.9×
Current ratio0.5×-0.5×